The estimated 15 year period, $800m (€509) investment and one in 5,000 chance of successfully developing a new drug is likely to see more and more pharmaceutical firms partner with CROs in a bid to offset risk, according to a report Turner Investment...
ClinPhone's shareholders have now approved the acquisition of the company by Parexel after rival Quintiles withdrew from the race to buy the eClinical technology company.
in-PharmaTechnologist.com's round-up of developments in the pharmaceutical manufacturing space features news of a fire at MY Healthcare, Helsinn's FDA approval and a safety award for Wyeth.
Roche’s proposed $44bn acquisition of Genentech is facing some opposition with Wall Street saying the offer undervalues the company, disquiet among the biotech’s employees and shareholders suing the Swiss giant.
UK researchers have used the ReNcell VM stem cell line, licensed by Millipore from UK stem cell therapy experts ReNeuron, to model neural degeneration observed in Parkinson's disease.
Thermo Fisher Scientific has followed up its acquisition of Open Biosystems with the purchase of antibody experts Affinity BioReagents to further bolster its protein research offering.
US physicists have built the world's most sensitive 'nanomechanical mass spectrometer' that can accurately determine the mass of objects lighter than a single gold atom.
Laboratory services and diagnostics company Medtox Scientific has posted a healthy hike in operating profits for the second quarter, despite a challenging operating environment that pegged back sales growth.
UK-headquartered ESA Biosciences has unveiled a new system for the identification of low levels organic impurities during the production of active pharmaceutical ingredients (API).
With fears of a global recession riding on the back of the credit crisis, many laboratory suppliers have managed to weather the storm and still achieve double digit sales growth in the second quarter of 2008.
Lonza of Switzerland is reaping the benefit of a shift away from bulk chemicals and towards custom manufacturing of high-value pharmaceuticals with a 13 per cent hike in sales in the first half of the year.
West African states are meeting to devise a plan for cleaning up their tarnished reputations with regards to the flow of counterfeit pharmaceuticals in the region.
Researchers from India and Japan claim to have developed a compact medical device capable of painlessly monitoring a patients insulin levels and administering the required dose.
The US Food and Drug Administration (FDA) has relaxed the regulatory good manufacturing practice (GMP) rules for drugs in early-stage clinical trials in recognition of the different requirements of trial scale and industrial scale manufacture.
The pace of change at GlaxoSmithKline (GSK) is showing no sign of slowing, with new CEO Andrew Witty unveiling the company’s new strategic direction with the release of second quarter results.
US drug giant Merck & Co hopes that an additional $300m (€190m) investment in its vaccine manufacturing plant in Durham, North Carolina will cement its position at the forefront of the global vaccines market
In an ironic twist, researchers have shown that the tobacco plant, the cause of millions of cases of cancer, can be harnessed to produce personalised cancer vaccines.
Midas Pharma and Capsulution NanoScience have entered into a long-term cooperation agreement, with contract manufacturing capacity and other services being provided in exchange for access to drug delivery technology.
India's Jubilant Biosys, a subsidiary of Jubilant Organosys, has scored a major deal with US biotech giant Amgen for the provision of early-stage drug discovery services.
Novartis’ extension of its collaboration with Alnylam Therapeutics and Roche’s acquisition of gene silencing specialist Mirus Bio Corp for $125m (€78.5m) suggest that big pharma is beginning to recognize the commercial potential of RNAi-based therapeutics.
Plastic packaging specialist China Bottles (CB) says that nearly two thirds of the $3.3m worth of contracts it signed in June were with pharmaceutical companies based outside its home territory.
Outsourcing-Pharma.com presents its periodic round-up of personnel changes in the pharmaceutical outsourcing arena, with senior appointments at Bristol-Myers Squibb, Parexel and GVK Bio, amongst others.
The pharmaceutical industry’s poor reputation among the public, a lack of understanding of clinical research and the increasing complexity of trials are all problems affecting patient recruitment, but greater use of the Internet could be a solution, according...
Supply and manufacturing contracts signed during fiscal 2008 helped India's Hikal achieve first quarter sales of Rs 920m ($21.5m), up 63 per cent on the year-earlier comparable period.
Roche offered this morning to take complete control of US biotechnology giant Genentech for the princely sum of $43.7bn in a move that it says would “enhance innovation” and cut costs for both companies.
Life science tools and services company MDS Inc has said it will cut about 210 jobs at two of its divisions - its MDS Pharma Services and MDS Analytical Technologies – in a bid to reduce costs by around $20m a year.
The US Food and Administration says that a new project examining the interaction between its review and facilities inspection arms will help improve inter-departmental communication, particularly during pre-approval inspections (PAI)
US software company Conformia hopes that its new web-based drug development suite will help pharmaceutical firms meet with new quality by design (QbD) and risk management guidelines.
A man has been sentenced in the US to four years imprisonment for trafficking 38,000 counterfeit Viagra (sildenafil citrate) tablets with a wholesale value of $400,000.
Brookwood Pharmaceuticals, a subsidiary of SurModics, has acquired the exclusive rights to all pharmaceutical applications of PharmaSol’s nanostructured lipid carrier (NLC) technology.
Bio-Rad has launched a new web-based search tool to give researchers easier access to its validated siLentMer gene silencing product line, which offers up to twice the silencing longevity.
Nanopoint has launched the 'world's most advanced' on-microscope cell containment device that offers complete environmental control for time-lapse cell imaging applications.
Thermo Fisher Scientific has integrated Genedata's Expressionist software with its high resolution mass spectrometry (MS) offering to enable high-throughput metabolomics data processing.
Scientists have completed the most comprehensive mammalian transcriptome analysis to date and believe the results should further our understanding of disease pathways.
Caliper Life Sciences has launched two new microfluidic-based electrophoresis instruments designed to address the separation needs of proteomic and genomic researchers.
3M Drug Delivery Systems believes it has made an advance in the
administration of high potency therapeutics through the skin using
its solid microstructured transdermal system (sMTS).
Acquisitive Indian contract research organisation Veeda has added
another company to its portfolio, buying International Oncology
Network (ION) of the US.
Ranbaxy has claimed that a pharmaceutical company is making a
concerted effort to depress the company's share price by initiating
the accusations that the generics manufacturer falsified data to
achieve compliance.
A new excipient could help drugmakers improve the delivery profiles
of active pharmaceutical ingredients (API), according to US
developer Eastman Chemical.
Pharmaceutical companies in the developed world have already
shifted substantial manufacturing and clinical trial work to
emerging economies such as China and India, but a new study suggest
they are increasingly counting on these...
Modigene says that data from a trial of a Schering-Plough's (SP)
fertility stimulation hormone (FSH-CTP) confirms that carboxyl
terminal peptide (CTP) modification can extend the therapeutic
duration of protein drugs.
The new AccuSpray spray gun can reduce the amount of magnesium
stearate that pharmaceutical firms require during drug manufacture,
according to developer Oystar Manesty.
Contract research organisation MDS Pharma Services has launched a
new version of its ClinQuick electronic data capture (EDC) system
designed to help in the design and management of Phase I clinical
studies.
Lonza is to co-develop and manufacture Novartis' biological pipeline as part of a long term strategic partnership that has been struck between the companies.